Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
about
Population-based epidemiology and microbiology of community-onset bloodstream infectionsEpidemiology and risk factors for invasive candidiasisEpidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated CandidemiaEpidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in ItalyTemporal Trends in Blood Stream Infection Isolates from Surgical PatientsFungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.Population-based analysis of invasive fungal infections, France, 2001-2010.Candidemia in patients with prolonged fever in Kashan, Iran.Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.Epidemiology of candidemia in Latin America: a laboratory-based survey.Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China.The Effect on mortality of fluconazole or echinocandins treatment in candidemia in internal medicine wards [corrected].Candida parapsilosis and the neonate: epidemiology, virulence and host defense in a unique patient setting.Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.Nationwide study of candidemia, antifungal use, and antifungal drug resistance in Iceland, 2000 to 2011Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia across five sites in Italy and Spain.Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in BrazilTen-year review of candidemia in a Canadian tertiary care centre: Predominance of non-albicans Candida species.Candida albicans and cancer: Can this yeast induce cancer development or progression?Candidaemia observed at a university hospital in Milan (northern Italy) and review of published studies from 2010 to 2014.Antifungal drug resistance among Candida species: mechanisms and clinical impact.Neonatal invasive candidiasis in Tunisian hospital: incidence, risk factors, distribution of species and antifungal susceptibility.The current treatment landscape: candidiasis.Differences in epidemiology of candidaemia in the Nordic countries - what is to blame?Candida bloodstream infections in Serbia: first multi-center report of a national prospective observational survey in intensive care units.Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014.Epidemiology of candidaemia in a tertiary care university hospital: 10-year experience with 381 candidaemia episodes between 2001 and 2010.Secular Trends in Central Line-Associated Bloodstream Infection: Microbiological Pattern of Pathogens after Preventive Measures.Epidemiology of Candida blood stream infections in patients with hematological malignancies or solid tumors.Update from a twelve-year nationwide fungaemia surveillance: increasing intrinsic and acquired resistance causes concern.Changes in the epidemiological landscape of invasive candidiasis.Epidemiology, practice patterns, and prognostic factors for candidemia; and characteristics of fourteen patients with breakthrough Candida bloodstream infections: a single tertiary hospital experience in Japan.Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference Laboratories
P2860
Q27013639-63810B0D-272A-4BC1-90C8-174124698753Q27024911-A7E207BD-C665-49FA-ADB0-CD9F52713374Q28109664-89A49FF2-0906-45E0-BA97-803F7CB0BED7Q28740362-DD11AED8-828C-49ED-A724-6B54EC934D74Q30279195-48F3B00D-0CB8-449F-80A3-4E49DD09CEB6Q30808061-19C746BA-F5B7-4F18-AC56-94EB7DE49291Q33816423-19638088-603D-44AE-BC1C-3FFF46CB8FFAQ33851292-D39BBE34-D995-47C7-B850-A6BE71BFADFDQ34372192-94778D06-BE6B-4085-99AD-414C42121FB3Q34635088-4539EC21-46C1-497A-B343-7A85972A0EBFQ34856747-83C475B6-E31D-4CF0-B338-592ADCA88F3FQ35566061-14C84BE3-79C3-4A7D-9818-E13D00374A66Q36401437-3AD69325-A642-4E9D-8EDD-9AB179FE9A17Q36434403-C3F2AD52-C4EC-4ECA-95F3-CFC954A6A00DQ36667530-CF85ADF7-162A-4D65-AC1F-3E12F19F571FQ36933437-2C7C1E01-E60D-4410-BEB2-A9D4F734CFAEQ37336194-7EACD27E-2A92-4A98-86EF-87C09920A3DBQ37734169-FCB286DF-6BDF-4F0F-948B-4BB75A2D680FQ38178257-CA23A22E-8238-4840-A866-17ECC0C28AFDQ38223120-EADEF58F-06EB-47B3-8034-669AF551F8DFQ38233262-FB7D1A88-715C-4BC5-9AA2-00C6A628F3C6Q38511946-F4697463-D516-4F1C-9740-346359A72473Q38901652-E62EDCF9-AA46-4A31-9C6E-626ED11D4124Q39018200-A51DDBD0-87A0-4B0D-8108-1C8AA2BE08E6Q39553745-0484AE67-3FA3-4450-B27B-AEC3D68F9ED3Q40057640-37A3231D-253C-42CB-ABD5-694A634DAE5BQ40496543-54A411BF-C6E0-4E31-B10D-96405D0FC5ECQ40757551-86547E1E-ECD8-49B3-A6A3-E400F7CAEE99Q41193913-80F61126-6CDE-4142-9E1E-8CD3A8CBB97CQ46098829-D0A43BF9-1BAF-4997-83E7-E8E2B96C419BQ47355716-CE87D877-4DF4-468D-9BC6-25140FB455F2Q47749844-D61A387E-C9E7-4E0E-9BAD-20A3B04384B0Q55292648-EEBC0FAA-9F09-4214-9D06-A26A24172CA0Q58701180-937F083A-3717-4FFD-9F57-9391F1808D7F
P2860
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@ast
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@en
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@nl
type
label
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@ast
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@en
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@nl
prefLabel
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@ast
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@en
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@nl
P2093
P2860
P356
P1476
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007
@en
P2093
Eira Poikonen
Hannu Syrjälä
Irma Koivula
Jukka Lumio
Petri Ruutu
Pirkko Kotilainen
Veli-Jukka Anttila
P2860
P2888
P356
10.1186/1471-2334-10-312
P577
2010-10-28T00:00:00Z
P5875
P6179
1032244563